Skip to main content
Clinical Research

Full-Spectrum Research Across 9 Therapeutic Areas

From first-in-human Phase I studies to pivotal Phase III trials, Delta Clinical Research offers sponsors a fully-staffed, FDA-certified site in Tampa Bay.

9 Therapeutic Areas Phase I–IV Certified Zero FDA Deficiencies 3 FL Locations
Expertise

Therapeutic Areas

Our team brings specialized expertise across a broad range of medical conditions.

Immunology & Allergy

8 studies

Atopic dermatitis, asthma, food allergy, and autoimmune diseases including rheumatoid arthritis and psoriasis.

Cardiology

5 studies

Heart failure, hypertension, atrial fibrillation, dyslipidemia, and atherosclerosis.

Neurology & CNS

7 studies

Migraine, epilepsy, Parkinson's disease, multiple sclerosis, and cognitive disorders.

Rare Disease

3 studies

Orphan diseases, enzyme deficiencies, lysosomal storage disorders, and rare metabolic conditions.

Women's Health

4 studies

Menopause management, endometriosis, PCOS, and reproductive health.

Infectious Disease

6 studies

Antiviral therapies, respiratory infections, fungal infections, and vaccine studies.

Metabolic & Endocrine

6 studies

Type 2 diabetes, obesity, NAFLD/NASH, and thyroid disorders.

Dermatology

5 studies

Psoriasis, chronic pruritus, rosacea, hidradenitis suppurativa, and alopecia areata.

Ophthalmology

3 studies

Age-related macular degeneration, diabetic retinopathy, dry eye disease, and glaucoma.

Trial Phases

Phase I–IV Capabilities

Delta is one of the few independent sites in Florida with full Phase I–IV certification.

Phase I

Safety & Dosing

First-in-human studies in small groups (20–80 participants) to evaluate safety, dosage, and side effects. Delta is Phase I certified.

Phase II

Efficacy Testing

Larger studies (100–300 participants) to determine if the intervention works and to evaluate safety in a larger population.

Phase III

Pivotal Trials

Large-scale trials (1,000–3,000 participants) confirming effectiveness, monitoring adverse reactions, and comparing to standard treatments.

Phase IV

Post-Market Studies

Post-approval studies to gather additional information on long-term safety, efficacy, and optimal use in real-world populations.

Where We Are

3 Tampa Bay Locations

Tampa Main Office

6319 Memorial Highway
Tampa, FL 33615

Mon–Fri 7:00am – 6:00pm
Get Directions

Clearwater Office

2900 Drew Street, Suite 200
Clearwater, FL 33759

Mon–Fri 8:00am – 5:00pm
Get Directions

St. Petersburg Office

4200 Tyrone Blvd N, Suite 100
St. Petersburg, FL 33709

Mon–Fri 8:00am – 5:00pm
Get Directions

Interested in Partnering With Us?

Sponsors and CROs trust Delta for our rigorous protocols, experienced team, and high enrollment rates.

Sponsor Information